Redhill Biopharma Ltd.
- Industry Drug Manufacturers - Specialty & Generic
- Sector Healthcare
- Market Cap
- Earnings
About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
RDHL
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- RedHill Biopharma announces plan to implement ADS ratio change
- RedHill to get US patent linked to bacterial infection drug
- RedHill shares gain 21% on peer-reviewed data publication of its COVID-19 antiviral
- RedHill's Aemcolo granted FDA 5-year exclusivity extension
- RedHill GAAP EPS of -$0.06, revenue of $17.55M
- RedHill Biopharma rises 6% on positive data from opaganib for nuclear radiation injury
- RedHill rises on plans to settle debt in exchange for rights to constipation drug Movantik
- RedHill oral antiviral opaganib gets US patent for COVID treatment
- RedHill Biopharma receives Nasdaq notification regarding minimum bid price deficiency
- RedHill wins EU’s orphan drug status to RHB-204 for rare lung disease
- RedHill GAAP EPS of -$0.03 in-line, revenue of $18.2M misses by $5.4M
- RedHill Biopharma to raise $15M in equity offering
- RedHill posts lab data to support efficacy of COVID-19 drug against Omicron
- RedHill GAAP EPS of -$0.21 beats by $0.78, revenue of $85.76M misses by $2.14M
- RedHill inks license deal with Kukbo for oral COVID drug opaganib in South Korea
- RedHill Biopharma COVID treatment reduces severe symptoms in mid-stage trial
- RedHill Biopharma preliminary Q4 net revenue falls short of estimates
- RedHill Biopharma says oral COVID-19 therapy lowered mortality in hospitalized patients
- RedHill says oral COVID-19 therapy improved viral clearance in severely ill patients
- RedHill Biopharma inks licensing deal for Talicia in UAE
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 | 2.280 | 1.830 |
2.380
|
1.830
|
873.20K | 24.59% | ||||
| Mar 16 | 1.830 | 1.750 |
1.830
|
1.710
|
398.37K | 10.91% | ||||
| Mar 15 | 1.650 | 1.650 |
1.690
|
1.600
|
678.47K | -1.2% | ||||
| Mar 14 | 1.670 | 1.770 |
1.770
|
1.650
|
204.87K | -3.47% | ||||
| Mar 11 | 1.730 | 1.880 |
1.880
|
1.700
|
202.96K | -6.49% | ||||
| Mar 10 | 1.850 | 1.910 |
1.970
|
1.830
|
107.90K | -4.64% | ||||
| Mar 9 | 1.940 | 1.790 |
1.960
|
1.760
|
282.01K | 12.79% | ||||
| Mar 8 | 1.720 | 1.680 |
1.770
|
1.610
|
332.92K | 2.99% | ||||
| Mar 7 | 1.670 | 1.700 |
1.730
|
1.670
|
242.25K | -3.47% | ||||
| Mar 4 | 1.730 | 1.850 |
1.900
|
1.700
|
370.21K | -6.99% | ||||
| Mar 3 | 1.860 | 2.020 |
2.040
|
1.850
|
468.09K | -7.46% | ||||
| Mar 2 | 2.010 | 1.970 |
2.130
|
1.960
|
588.76K | 2.03% | ||||
| Mar 1 | 1.970 | 2.200 |
2.210
|
1.950
|
680.14K | -10.05% | ||||
| Feb 28 | 2.190 | 2.150 |
2.250
|
2.130
|
141.17K | 0.92% | ||||
| Feb 25 | 2.170 | 2.110 |
2.239
|
2.110
|
143.23K | 1.40% | ||||
| Feb 24 | 2.140 | 2.000 |
2.140
|
1.945
|
335.28K | 0.47% | ||||
| Feb 23 | 2.130 | 2.260 |
2.300
|
2.120
|
509.43K | -6.17% | ||||
| Feb 22 | 2.270 | 2.300 |
2.360
|
2.220
|
320.28K | -2.99% | ||||
| Feb 18 | 2.340 | 2.340 |
2.380
|
2.260
|
289.78K | 1.74% | ||||